Loading live market data…

Nektar Therapeutics

NASDAQ:NKTR

$67.17 USD

-$1.15 (-1.68%)

Volume
814.75K
Average Volume
1.17M
Market Capitalization
$1.31B
P/E Ratio
-7.98
Dividend Yield
0.00%
Price Target
$151.00
Year High
$109.00
Year Low
$21.02
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$10.21

NKTR Estimated and Actual Revenue by Quarter

NKTR Estimated and Actual EPS by Quarter

NKTR Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2029-12-31 7 -11.67M -7.9M -10.6M -11.78M -7.97M -10.7M
2029-09-30 4 -11.67M -7.9M -10.6M -11.78M -7.97M -10.7M
2029-06-30 6 -11.67M -7.9M -10.6M -11.78M -7.97M -10.7M
2029-03-31 4 -11.67M -7.9M -10.6M -11.78M -7.97M -10.7M
2028-12-31 6 -11.48M -7.77M -10.43M -11.58M -7.84M -10.52M
2028-09-30 3 -11.48M -7.77M -10.43M -11.58M -7.84M -10.52M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2029-12-31 7 -94.59M -55.88M -83.61M 8.24M 12.18M 11.06M
2029-09-30 4 -93.96M -55.51M -83.04M 8.24M 12.18M 11.06M
2029-06-30 6 -100.9M -59.61M -89.18M 8.24M 12.18M 11.06M
2029-03-31 4 -98.97M -58.47M -87.48M 8.24M 12.18M 11.06M
2028-12-31 6 -92.99M -54.94M -82.19M 8.1M 11.97M 10.87M
2028-09-30 3 -95.56M -56.45M -84.46M 8.1M 11.97M 10.87M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2029-12-31 7 8.09M 11.96M 10.86M 4 -3.82415 -2.25922 -3.3799
2029-09-30 4 8.09M 11.96M 10.86M 3 -3.79846 -2.24404 -3.3572
2029-06-30 6 8.09M 11.96M 10.86M 3 -4.07906 -2.40981 -3.6052
2029-03-31 4 8.09M 11.96M 10.86M 4 -4.00122 -2.36382 -3.5364
2028-12-31 6 7.96M 11.76M 10.68M 3 -3.75926 -2.22088 -3.32255
2028-09-30 3 7.96M 11.76M 10.68M 3 -3.86307 -2.28221 -3.4143